ReviewMicrobial cell factories2026
A comparative framework of natural nisin variants: linking genetic basis to future bioengineering applications.
Review in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNisin is a commercially successful antimicrobial peptide (AMP) widely used as a food preservative. As a ribosomally synthesized and post-translationally modified peptide (RiPP), nisin belongs to a diverse family of natural variants. However, despite its importance, a systematic and comprehensive comparison of the biosynthetic gene clusters and resulting structural diversity across the entire nisin family has been a critical gap in the literature.
resultsThis review provides the first comprehensive, side-by-side analysis of nisin A and all its known natural variants. We systematically compare their biosynthetic gene clusters (BGCs), post-translational modification pathways, and final amino acid sequences. This comparative analysis reveals direct correlations between the genetic architecture of each variant and its resulting structural and functional properties. By collating and organizing this information, this work establishes a critical resource that clarifies the molecular basis for the functional diversity observed in the nisin family.
conclusionsThis study provides a foundational framework for understanding the natural diversity of nisin. The established links between genotype and phenotype serve as a rational guide for future bioengineering efforts aimed at developing novel nisin derivatives with improved stability, solubility, or specific antimicrobial activity. In the face of growing antibiotic resistance, harnessing this natural diversity holds significant potential for creating new therapeutic agents that extend beyond nisin’s traditional role in food preservation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.